Blanch L, Joseph D, Fernández R, Mas A, Martinez M, Vallés J, Diaz E, Baigorri F, Artigas A
Intensive Care Service, Hospital de Sabadell, Spain.
Intensive Care Med. 1997 Jan;23(1):51-7. doi: 10.1007/s001340050290.
Inhalation of nitric oxide (NO) can improve oxygenation and decrease mean pulmonary artery pressure (MPAP) in patients with the acute respiratory distress syndrome (ARDS). It is not known whether inhaled NO exerts a similar effect in hypoxemic patients with chronic obstructive pulmonary disease (COPD).
Prospective clinical study.
General intensive care unit in Sabadell, Spain.
Nine mechanically ventilated COPD patients (mean age 72 +/- 2 years; forced expiratory volume in 1 s 0.91 +/- 0.11 l) and nine ARDS patients (mean age 57 +/- 6 years; mean lung injury score 2.8 +/- 0.1).
We measured hemodynamic and gas exchange parameters before NO inhalation (basal 1), during inhalation of 10 ppm NO (NO-10), and 20 min after NO was discontinued (in basal 2) in the ARDS group. In the COPD group, these parameters were measured before NO inhalation (basal 1), during different doses of inhaled NO (10, 20, and 30 ppm), and 20 min after NO was discontinued (basal 2). A positive response to NO was defined as a 20% increment in basal arterial partial pressure of oxygen (PaO2). MPAP and pulmonary vascular resistance (PVR) decreased significantly, while other hemodynamic parameters remained unchanged after NO-10 in both groups. Basal oxygenation was higher in the COPD group (PaO2/FIO2 (fractional inspired oxygen) 190 +/- 18 mmHg) than in the ARDS group (PaO2/FIO2 98 +/- 12 mmHg), (p < 0.01). After NO-10, PaO2/FIO2 increased (to 141 +/- 17 mmHg, p < 0.01) and Qva/Qt decreased (39 +/- 3 to 34 +/- 3%, p < 0.01) in the ARDS group. There were no changes in PaO2/FIO2 and Qva/Qt when the NO concentration was increased to 30 ppm in the COPD group. In both groups, a correlation was found between basal MPAP and basal PVR, and between the NO-induced decrease in MPAP and in PVR. The NO-induced increase in PaO2/FIO2 was not correlated with basal PaO2/FIO2. In the ARDS group, six of the nine patients (66%) responded to NO and in the COPD group, two of nine (22%) (p = 0.05).
NO inhalation had similar effects on hemodynamics but not on gas exchange in ARDS and COPD patients, and this response probably depends on the underlying disease.
吸入一氧化氮(NO)可改善急性呼吸窘迫综合征(ARDS)患者的氧合并降低平均肺动脉压(MPAP)。目前尚不清楚吸入NO对慢性阻塞性肺疾病(COPD)低氧血症患者是否有类似作用。
前瞻性临床研究。
西班牙萨瓦德尔的综合重症监护病房。
9例机械通气的COPD患者(平均年龄72±2岁;第1秒用力呼气量0.91±0.11升)和9例ARDS患者(平均年龄57±6岁;平均肺损伤评分2.8±0.1)。
我们在ARDS组中测量了吸入NO前(基础1)、吸入10 ppm NO期间(NO-10)以及停止吸入NO 20分钟后(基础2)的血流动力学和气体交换参数。在COPD组中,这些参数在吸入NO前(基础1)、吸入不同剂量的NO(10、20和30 ppm)期间以及停止吸入NO 20分钟后(基础2)进行测量。对NO的阳性反应定义为基础动脉血氧分压(PaO2)增加20%。两组在吸入NO-10后,MPAP和肺血管阻力(PVR)显著降低,而其他血流动力学参数保持不变。COPD组的基础氧合水平(PaO2/吸入氧分数(FIO2)为190±18 mmHg)高于ARDS组(PaO2/FIO2为98±12 mmHg),(p<0.01)。在ARDS组中,吸入NO-10后,PaO2/FIO2升高(至141±17 mmHg,p<0.01),肺内分流率(Qva/Qt)降低(从39±3%降至34±3%,p<0.01)。在COPD组中,当NO浓度增加到30 ppm时,PaO2/FIO2和Qva/Qt无变化。两组中均发现基础MPAP与基础PVR之间以及NO诱导的MPAP和PVR降低之间存在相关性。NO诱导的PaO2/FIO2升高与基础PaO2/FIO2无关。在ARDS组中,9例患者中有6例(66%)对NO有反应,在COPD组中,9例中有2例(约22%)(p = 0.05)。
吸入NO对ARDS和COPD患者的血流动力学有类似影响,但对气体交换的影响不同,这种反应可能取决于基础疾病。